Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
Immunofluorescent analysis of SETDB2 showing staining in the nucleus of HCT116 cells. HCT116 cells were fixed in 4% paraformaldehyde at RT for 15 min and stained using a SETDB2 polyclonal antibody (Product # PA5-30848) diluted at 1:500. Blue: Hoechst 33342 staining. Scale bar = 10µm.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant protein fragment corresponding to a region within amino acids 1 and 160 of Human SETDB2|
|Purification||Antigen affinity chromatography|
|Storage buffer||PBS, pH 7, with 20% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA5-30848 targets SETDB2 in WB applications and shows reactivity with Human samples.
The PA5-30848 immunogen is recombinant protein fragment corresponding to a region within amino acids 1 and 160 of Human SETDB2.
Proteins that contain a SET domain, such as SETDB2, modulate gene expression epigenetically through histone H3 (see MIM 601128) methylation. SETDB2 is likely a histone H3 methyltransferase, as it contains both the active site and flanking cysteine residues required for catalytic activity (Zhang et al., 2003 [PubMed 12754510]).
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
C13orf4; chronic lymphocytic leukemia deletion region 8; chronic lymphocytic leukemia deletion region gene 8 protein; CLLD8; CLLL8; histone-lysine N-methyltransferase SETDB2; KMT1F; lysine N-methyltransferase 1F
C13orf4; CLLD8; CLLL8; KMT1F; SETDB2